Index 
 Previous 
 Next 
 Full text 
Procedure : 2005/0227(COD)
Document stages in plenary
Document selected : A6-0031/2007

Texts tabled :

A6-0031/2007

Debates :

PV 23/04/2007 - 17
CRE 23/04/2007 - 17

Votes :

PV 25/04/2007 - 11.1
CRE 25/04/2007 - 11.1
Explanations of votes

Texts adopted :

P6_TA(2007)0144

Minutes
Monday, 23 April 2007 - StrasbourgFinal edition

17. Advanced therapy medicinal products ***I (debate)
CRE

Report on the proposal for a regulation of the European Parliament and of the Council on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004 [COM(2005)0567 - C6-0401/2005 - 2005/0227(COD)] - Committee on the Environment, Public Health and Food Safety. Rapporteur: Miroslav Mikolášik (A6-0031/2007)

Günter Verheugen (Vice-President of the Commission) spoke.

IN THE CHAIR: Marek SIWIEC
Vice-President

Miroslav Mikolášik introduced the report.

The following spoke: Giles Chichester (draftsman of the opinion of the ITRE Committee), Hiltrud Breyer (draftsman of the opinion of the JURI Committee), John Bowis, on behalf of the PPE-DE Group, Dagmar Roth-Behrendt, on behalf of the PSE Group, Frédérique Ries, on behalf of the ALDE Group, Konrad Szymański, on behalf of the UEN Group, Hiltrud Breyer, on behalf of the Verts/ALE Group, Adamos Adamou, on behalf of the GUE/NGL Group, Johannes Blokland, on behalf of the IND/DEM Group, Françoise Grossetête, Proinsias De Rossa, Marios Matsakis, Urszula Krupa, Peter Liese, Jorgo Chatzimarkakis, Kathy Sinnott, Antonios Trakatellis, Péter Olajos, John Purvis, Carlo Casini, Bogusław Sonik, Klaus Theo Schröder (President-in-Office of the Council) and Günter Verheugen

The debate closed.

Vote: Minutes of 25.04.2007, Item 11.1.

Last updated: 5 October 2007Legal notice